Literature DB >> 30891468

Initial evaluation of three-dimensionally printed patient-specific coronary phantoms for CT-FFR software validation.

Lauren M Shepard1,2, Kelsey N Sommer1,2, Erin Angel3, Vijay Iyer4, Michael F Wilson4, Frank J Rybicki5, Dimitrios Mitsouras5, Sabee Molloi6, Ciprian N Ionita1,2,7.   

Abstract

We developed three-dimensionally (3D) printed patient-specific coronary phantoms that are capable of sustaining physiological flow and pressure conditions. We assessed the accuracy of these phantoms from coronary CT acquisition, benchtop experimentation, and CT-FFR software. Five patients with coronary artery disease underwent 320-detector row coronary CT angiography (CCTA) (Aquilion ONE, Canon Medical Systems) and a catheter lab procedure to measure fractional flow reserve (FFR). The aortic root and three main coronary arteries were segmented (Vitrea, Vital Images) and 3D printed (Eden 260V, Stratasys). Phantoms were connected into a pulsatile flow loop, which replicated physiological flow and pressure gradients. Contrast was introduced and the phantoms were scanned using the same CT scanner model and CCTA protocol as used for the patients. Image data from the phantoms were input to a CT-FFR research software (Canon Medical Systems) and compared to those derived from the clinical data, along with comparisons between image measurements and benchtop FFR results. Phantom diameter measurements were within 1 mm on average compared to patient measurements. Patient and phantom CT-FFR results had an absolute mean difference of 4.34% and Pearson correlation of 0.95. We have demonstrated the capabilities of 3D printed patient-specific phantoms in a diagnostic software.

Entities:  

Keywords:  CT-FFR; blood flow simulations; coronary CT angiography; coronary phantoms; patient specific 3D printed phantoms

Year:  2019        PMID: 30891468      PMCID: PMC6411941          DOI: 10.1117/1.JMI.6.2.021603

Source DB:  PubMed          Journal:  J Med Imaging (Bellingham)        ISSN: 2329-4302


  22 in total

Review 1.  Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I--Pathophysiological and pharmacological features.

Authors:  A I Qureshi; A R Luft; M Sharma; L R Guterman; L N Hopkins
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

Review 2.  Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II--Clinical aspects and recommendations.

Authors:  A I Qureshi; A R Luft; M Sharma; L R Guterman; L N Hopkins
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

Review 3.  Functional measurement of coronary stenosis.

Authors:  Nico H J Pijls; Jan-Willem E M Sels
Journal:  J Am Coll Cardiol       Date:  2012-03-20       Impact factor: 24.094

4.  Fractional flow reserve-guided revascularization: practical implications of a diagnostic gray zone and measurement variability on clinical decisions.

Authors:  Ricardo Petraco; Sayan Sen; Sukhjinder Nijjer; Mauro Echavarria-Pinto; Javier Escaned; Darrel P Francis; Justin E Davies
Journal:  JACC Cardiovasc Interv       Date:  2013-03       Impact factor: 11.195

5.  Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study.

Authors:  Bon-Kwon Koo; Andrejs Erglis; Joon-Hyung Doh; David V Daniels; Sanda Jegere; Hyo-Soo Kim; Allison Dunning; Tony DeFrance; Alexandra Lansky; Jonathan Leipsic; James K Min
Journal:  J Am Coll Cardiol       Date:  2011-11-01       Impact factor: 24.094

6.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.

Authors:  Pim A L Tonino; Bernard De Bruyne; Nico H J Pijls; Uwe Siebert; Fumiaki Ikeno; Marcel van' t Veer; Volker Klauss; Ganesh Manoharan; Thomas Engstrøm; Keith G Oldroyd; Peter N Ver Lee; Philip A MacCarthy; William F Fearon
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 91.245

7.  Treatment Planning for Image-Guided Neuro-Vascular Interventions Using Patient-Specific 3D Printed Phantoms.

Authors:  M Russ; R O'Hara; S V Setlur Nagesh; M Mokin; C Jimenez; A Siddiqui; D Bednarek; S Rudin; C Ionita
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-19

8.  Diagnostic accuracy of fractional flow reserve from anatomic CT angiography.

Authors:  James K Min; Jonathon Leipsic; Michael J Pencina; Daniel S Berman; Bon-Kwon Koo; Carlos van Mieghem; Andrejs Erglis; Fay Y Lin; Allison M Dunning; Patricia Apruzzese; Matthew J Budoff; Jason H Cole; Farouc A Jaffer; Martin B Leon; Jennifer Malpeso; G B John Mancini; Seung-Jung Park; Robert S Schwartz; Leslee J Shaw; Laura Mauri
Journal:  JAMA       Date:  2012-09-26       Impact factor: 56.272

9.  Initial testing of a 3D printed perfusion phantom using digital subtraction angiography.

Authors:  Rachel P Wood; Parag Khobragade; Leslie Ying; Kenneth Snyder; David Wack; Daniel R Bednarek; Stephen Rudin; Ciprian N Ionita
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-03-17

10.  Challenges and limitations of patient-specific vascular phantom fabrication using 3D Polyjet printing.

Authors:  Ciprian N Ionita; Maxim Mokin; Nicole Varble; Daniel R Bednarek; Jianping Xiang; Kenneth V Snyder; Adnan H Siddiqui; Elad I Levy; Hui Meng; Stephen Rudin
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2014-03-13
View more
  2 in total

1.  Evaluation of challenges and limitations of mechanical thrombectomy using 3D printed neurovascular phantoms.

Authors:  Kelsey N Sommer; Mohammad Mahdi Shiraz Bhurwani; Maxim Mokin; Ciprian N Ionita
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2021-02-15

2.  Development of Custom Wall-Less Cardiovascular Flow Phantoms with Tissue-Mimicking Gel.

Authors:  Megan E Laughlin; Sam E Stephens; Jamie A Hestekin; Morten O Jensen
Journal:  Cardiovasc Eng Technol       Date:  2021-06-02       Impact factor: 2.495

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.